|
Tuesday 10th November 2020 |
Text too small? |
NZX Regulation advises that, at the request of the company, Abano Healthcare Group Limited (NZX: ABA ) ordinary shares remain in a halt.
The trading halt has been extended to allow for completion of an addendum report by Calibre Partners, the Independent Adviser under the scheme of arrangement proposal to reflect updated financial information provided by ABA, and to allow for that report to be considered by the parties to the scheme of arrangement and released.
The trading halt will remain in place until the earlier of:
• An announcement by ABA in relation to the updated information; or
• Market open on Thursday, 12 November 2020.
See the links below for more details:
ABA – Trading Halt of Securities
Source: Abano Healthcare Group Limited
No comments yet
HGH Ltd Results for the 6 months ended 1 February 2026
March 27th Morning Report
CDC investor presentation and guidance update
PFI - Potential Bond Offer by PFI
MCY - Mercury Green Bond offer - interest rate set
March 25th Morning Report
AFT - Chief Financial Officer update
KMD Brands: Response to Stokehouse transaction concept
March 24th Morning Report
MCY - Mercury launches retail Green Bond offer